Saltar al contenido
Merck

Documentos clave

Ver Toda la documentación

1.19637

LiChrospher® 100 RP-18 endcapped (5 µm) HPLC Columns

HPLC sorbent

Sinónimos:

TM=["LiChrospher"] C18 sorbent for HPLC

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

UNSPSC Code:
41115709
NACRES:
SB.52
Particle size:
5 μm
Matrix active group:
C18 (RP18), C18 bonding phase
Pore size:
100 Å pore size
Matrix:
fully porous particle
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

Nombre del producto

LiChrospher® 100 RP-18 endcapped (5 µm),

material

stainless steel column

agency

suitable for USP L1

product line

LiChrospher®

feature

endcapped

packaging

1 ea of

extent of labeling

21.6% Carbon loading

parameter

60 °C max. temp.

technique(s)

HPLC: suitable, mass spectrometry (MS): suitable (Low - Medium)

surface area

350 m2/g

matrix

fully porous particle

matrix active group

C18 (RP18), C18 bonding phase

particle size

5 μm

pore size

100 Å pore size

operating pH range

2-7.5

bulk density

200‑400 kg/m3

separation technique

reversed phase

storage temp.

no temp limit

General description

LiChrospher® RP-18 endcapped is a reliable and versatile traditionally produced spherical silica gel carrier with revered phase properties. It is well suited for the separation of neutral, acidic and weak basic compounds.

Application


  • Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD: The robustness of the LiChrospher® 60 RP-select B column is highlighted in forensic science, where it is used to accurately identify and quantify cannabinoids, demonstrating its critical role in legal and forensic analyses (Ambach et al., 2014).

  • RP-HPLC separation and characterization of unknown impurities of a novel HIV-protease inhibitor Darunavir by ESI-MS and 2D NMR spectroscopy: The LiChrospher® 60 RP-select B column′s exceptional selectivity and performance are utilized to identify novel impurities in Darunavir, highlighting its application in developing more effective HIV treatments (Nageswara Rao et al., 2013).

  • Quantification of pralidoxime (2-PAM) in urine by ion pair chromatography-diode array detection: Demonstrating versatility, this column was used to detect therapeutic agents in clinical settings, supporting treatment regimes for poisonings where rapid and accurate drug monitoring is essential (John et al., 2012).


Analysis Note

Application test: passes test
Pressure: ≤ 50 bar
Theoretical Plates (N/m) (Toluene): ≥ 60000
stability testing (performance): passes test
Particle Size (d10): 4.8 - 5.5 µm
Particle Size (d50): 6.5 - 7.5 µm
Particle Size (d90): 9.0 - 10.5 µm

Legal Information

LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany

Still not finding the right product?

Explore all of our products under LiChrospher® 100 RP-18 endcapped (5 µm)

Clase de almacenamiento

11 - Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos